Testicular Neoplasms Clinical Trial
Official title:
Randomized Phase 2 Study of Conventional Dose Chemotherapy Versus High Dose Sequential Chemotherapy as First-line Therapy for Metastatic Poor Prognosis Germ Cell Tumors
The purpose of this study is to determine whether the use of a sequential high dose chemotherapy is more effective than conventional dose (i.e. 4 cycles of cisplatin, etoposide, and bleomycin [PEB]) in patients with metastatic poor prognosis germ cell tumors.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00231582 -
High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II
|
Phase 2 | |
Terminated |
NCT02900248 -
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
|
||
Terminated |
NCT02577172 -
Testicular Cancer and Aerobic and Strength Training
|
N/A | |
Completed |
NCT03403777 -
Avelumab in Refractory Testicular Germ Cell Cancer.
|
Phase 2 | |
Completed |
NCT02890030 -
The Platinum Study Comparison Group
|
||
Recruiting |
NCT05264337 -
Lymphedema After Urologic Surgery
|
||
Active, not recruiting |
NCT03426865 -
Role of Axumin PET Scan in Germ Cell Tumor
|
||
Completed |
NCT00001270 -
Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma
|
Phase 1 | |
Completed |
NCT02459132 -
High-Intensity Aerobic Interval Training in Testicular Cancer Survivors
|
N/A | |
Completed |
NCT06309732 -
GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)
|
Phase 2 | |
Terminated |
NCT02499952 -
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
|
Phase 2 | |
Recruiting |
NCT02304575 -
Quality of Life Among Testicular Cancer Survivors
|
N/A | |
Withdrawn |
NCT02492360 -
Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
|
N/A | |
Completed |
NCT04122430 -
Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
|
||
Recruiting |
NCT02229916 -
Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
|
||
Completed |
NCT02966509 -
Engagement of Patients With Advanced Cancer
|
N/A | |
Recruiting |
NCT02341989 -
Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
|
Phase 3 | |
Completed |
NCT05056688 -
Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors
|
N/A | |
Terminated |
NCT05229900 -
A Study of SGN-ALPV in Advanced Solid Tumors
|
Phase 1 | |
Completed |
NCT00123773 -
Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence
|
Phase 2 |